Savara Inc (SVRA)
4.66
-0.41
(-8.09%)
USD |
NASDAQ |
May 10, 16:00
4.66
0.00 (0.00%)
After-Hours: 20:00
Savara Cash from Investing (Quarterly): 6.571M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.571M |
| September 30, 2023 | -56.59M |
| June 30, 2023 | -1.006M |
| March 31, 2023 | -6.095M |
| December 31, 2022 | -59.21M |
| September 30, 2022 | 33.00M |
| June 30, 2022 | 25.20M |
| March 31, 2022 | 53.66M |
| December 31, 2021 | -1.268M |
| September 30, 2021 | 12.98M |
| June 30, 2021 | -3.432M |
| March 31, 2021 | -77.74M |
| December 31, 2020 | -0.381M |
| September 30, 2020 | -6.861M |
| June 30, 2020 | 18.08M |
| March 31, 2020 | -1.785M |
| December 31, 2019 | 16.75M |
| September 30, 2019 | 6.59M |
| June 30, 2019 | -14.92M |
| March 31, 2019 | 7.32M |
| December 31, 2018 | 0.869M |
| September 30, 2018 | -35.71M |
| June 30, 2018 | 11.83M |
| March 31, 2018 | 9.39M |
| December 31, 2017 | -39.05M |
| Date | Value |
|---|---|
| September 30, 2017 | -33.44M |
| June 30, 2017 | 3.441M |
| March 31, 2017 | -0.059M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.003M |
| June 30, 2016 | -4.383M |
| March 31, 2016 | 4.378M |
| December 31, 2015 | -3.691M |
| September 30, 2015 | 4.431M |
| June 30, 2015 | -0.221M |
| March 31, 2015 | -0.519M |
| December 31, 2014 | -4.401M |
| September 30, 2014 | 2.812M |
| June 30, 2014 | -0.392M |
| March 31, 2014 | 2.462M |
| December 31, 2013 | 0.4264M |
| September 30, 2013 | -10.73M |
| June 30, 2013 | 2.136M |
| March 31, 2013 | 3.400M |
| December 31, 2012 | -0.2533M |
| September 30, 2012 | -0.703M |
| June 30, 2012 | -2.150M |
| March 31, 2012 | -4.059M |
| December 31, 2011 | -1.824M |
| September 30, 2011 | -5.708M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-77.74M
Minimum
Mar 2021
53.66M
Maximum
Mar 2022
-2.971M
Average
-1.006M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.60M |
| Cash from Financing (Quarterly) | 7.895M |
| Free Cash Flow | -51.36M |
| Free Cash Flow Per Share (Quarterly) | -0.0843 |
| Free Cash Flow Yield | -6.73% |